Defymed

4 articles about Defymed

• Defymed: Towards a Physiological Treatment for Type 1 Diabetes

  5/5/2020

  A new fund raising round for Defymed, to allow the entry into clinical phase of its ExOlin® device

• Innovative Medical Devices for the Treatment of Diabetes, Defymed Strengthens Its Position as a Worldwide Leader

  2/12/2018

  As part of this approach, two innovative medical devices, ExOlin® and MailPan®, have been developed by Defymed to provide patients with a more physiological treatment.

• Defymed Is Developing Exolin, A New Insulin Delivery Device

  7/10/2017

• Defymed Enters Partnership With Semma Therapeutics

  12/12/2016